NovaPoint Capital’s iShares iBonds Dec 2031 Term Corporate ETF IBDW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.39M Buy
66,724
+1,540
+2% +$32.1K 0.29% 73
2026
Q1
$1.36M Buy
65,184
+879
+1% +$18.6K 0.34% 68
2025
Q4
$1.36M Buy
64,305
+6,840
+12% +$145K 0.35% 66
2025
Q3
$1.22M Buy
57,465
+4,995
+10% +$105K 0.3% 69
2025
Q2
$1.1M Buy
52,470
+532
+1% +$11K 0.34% 64
2025
Q1
$1.08M Buy
51,938
+933
+2% +$19.1K 0.33% 66
2024
Q4
$1.04M Buy
51,005
+2,229
+5% +$46.1K 0.32% 65
2024
Q3
$1.04M Buy
48,776
+5,256
+12% +$110K 0.32% 66
2024
Q2
$883K Buy
+43,520
New +$878K 0.3% 67

Other funds holding IBDW

NovaPoint Capital's IBDW Position: Q2 2026 in Review

NovaPoint Capital increased its iShares iBonds Dec 2031 Term Corporate ETF (IBDW) stake by 2.4% in Q2 2026, buying an estimated $32.1K and bringing the position to 66,724 shares worth $1.39M. The position accounts for 0.29% of the portfolio, ranked #73.

NovaPoint Capital first reported a position in IBDW in Q2 2024 and has held it in 9 quarters since. 290 funds tracked by Wall St. Rank hold IBDW as of Q2 2026.

  • NovaPoint Capital held 66,724 shares of iShares iBonds Dec 2031 Term Corporate ETF worth $1.39M as of Q2 2026.
  • NovaPoint Capital bought 1,540 iShares iBonds Dec 2031 Term Corporate ETF shares in Q2 2026, an estimated $32.1K.
  • iShares iBonds Dec 2031 Term Corporate ETF made up 0.29% of NovaPoint Capital's portfolio in Q2 2026, its #73 holding.
  • NovaPoint Capital first reported a position in iShares iBonds Dec 2031 Term Corporate ETF in Q2 2024 and has held it in 9 quarters since.
  • 290 funds tracked by Wall St. Rank held iShares iBonds Dec 2031 Term Corporate ETF as of Q2 2026.

Based on NovaPoint Capital's 13F filing for Q2 2026, filed 6 Aug 2026.